Financhill
Back

Duff & Phelps Utility and Infrastructure Fund Vs. CRISPR Therapeutics AG Industry Stock Comparison

Buy
79

DPG
Duff & Phelps Utility and Infrastructure Fund

Last Price:
$12.67
Seasonality Move:
-1.06%
Sell
43

CRSP
CRISPR Therapeutics AG

Last Price:
$57.90
Seasonality Move:
14.46%
Buy
79
Duff & Phelps Utility and Infrastructure Fund (DPG) is a Buy

Is Duff & Phelps Utility and Infrastructure Fund a Buy, Sell or Hold?

  • The current Duff & Phelps Utility and Infrastructure Fund [DPG] share price is $12.66. The Score for DPG is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
  • DPG is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $55.86. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DPG Stock Price Chart

What is Duff & Phelps Utility and Infrastructure Fund's stock price today?

  • The Duff & Phelps Utility and Infrastructure Fund share price today is $12.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DPG is experiencing selling pressure, which indicates risk of future bearish movement.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $55.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight buying pressure.

DPG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 41.53 Sell
Chaikin Money Flow: -69826 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.65 - 13.09) Sell
Bollinger Bands (100): (12.58 - 13.1) Sell

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 49.16 Sell
Chaikin Money Flow: 78181 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.94 - 57.06) Buy
Bollinger Bands (100): (52.44 - 65.4) Sell

DPG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.61 Buy
20-day SMA: 12.81 Sell
50-day SMA: 12.99 Sell
200-day SMA: 12.49 Buy
8-day EMA: 12.66 Sell
20-day EMA: 12.77 Sell
50-day EMA: 12.86 Sell
200-day EMA: 12.49 Buy

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.25 Sell
20-day SMA: 55.05 Buy
50-day SMA: 58.96 Sell
200-day SMA: 51.1 Buy
8-day EMA: 55.79 Buy
20-day EMA: 55.79 Buy
50-day EMA: 56.36 Sell
200-day EMA: 37.56 Buy

Duff & Phelps Utility and Infrastructure Fund Earnings Growth & DPG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.

Duff & Phelps Utility and Infrastructure Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):